Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:680-685
doi: 10.1161/01.STR.0000251444.56487.4c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stenzel-Poore, M. P.
Right arrow Articles by Simon, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stenzel-Poore, M. P.
Right arrow Articles by Simon, R. P.
Related Collections
Right arrow Animal models of human disease
Right arrow Ischemic biology - basic studies
Right arrow Acute Cerebral Infarction
Right arrow Transient Ischemic Attacks

(Stroke. 2007;38:680.)
© 2007 American Heart Association, Inc.


Genomics of Ischemia: Introduction

Preconditioning Reprograms the Response to Ischemic Injury and Primes the Emergence of Unique Endogenous Neuroprotective Phenotypes

A Speculative Synthesis

Mary P. Stenzel-Poore, PhD; Susan L. Stevens, BS; Jeffrey S. King, PhD Roger P. Simon, MD

From Department of Molecular Microbiology and Immunology (M.P.S.-P., S.L.S.), Oregon Health & Science University, Portland, Ore; NeuroProtect, Inc. (J.S.K.), Portland, Ore; Robert S. Dow Neurobiology Laboratories (R.P.S.), Legacy Research, Portland, Ore.

Correspondence to Dr Mary Stenzel-Poore, Department of Molecular Microbiology and Immunology, Oregon Health & Science University, 3181 Sam Jackson Park Road, Portland, OR 97239. E-mail poorem{at}OHSU.edu

Abstract

Ischemic tolerance in the brain, in which sub-threshold insults increase resistance to subsequent injurious ischemia, is a powerful adaptive defense that involves an endogenous program of neuroprotection. Emerging evidence from genomic studies suggests diverse stimuli that trigger preconditioning achieve neuroprotection through a common process which depends on a fundamental reprogramming of the response to injury. Such reprogramming of the genomic response to injury leads to the induction of novel neuroprotective pathways not ordinarily found in the setting of ischemia. Genomic studies also indicate that the nature of the preconditioning stimulus (eg, brief ischemia or endotoxin [lipopolysaccharide]) dictates the phenotype of neuroprotection, a phenotype that parallels protective adaptations also found in certain physiological conditions where the preconditioning stimulus exists at levels that can induce injury. The idea that preconditioning leads to a fundamental reprogramming event that confers neuroprotection is a novel and important concept in the field of ischemic tolerance. Moreover, the view that distinct preconditioning stimuli confer neuroprotection via effectors that differ according to the nature of the preconditioning stimulus offers promise that multiple, nonoverlapping pathways may be discovered as novel neuroprotective therapies.


Key Words: genomics • neuroprotectants • preconditioning • Toll-like receptors • stroke




This article has been cited by other articles:


Home page
NeuroscientistHome page
R. Meller
The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance
Neuroscientist, June 1, 2009; 15(3): 243 - 260.
[Abstract] [PDF]


Home page
StrokeHome page
B. J. Marsh, S. L. Stevens, B. Hunter, and M. P. Stenzel-Poore
Inflammation and the Emerging Role of the Toll-Like Receptor System in Acute Brain Ischemia
Stroke, March 1, 2009; 40(3_suppl_1): S34 - S37.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Li and T. H. Murphy
Two-Photon Imaging during Prolonged Middle Cerebral Artery Occlusion in Mice Reveals Recovery of Dendritic Structure after Reperfusion
J. Neurosci., November 12, 2008; 28(46): 11970 - 11979.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. H. Murphy, P. Li, K. Betts, and R. Liu
Two-Photon Imaging of Stroke Onset In Vivo Reveals That NMDA-Receptor Independent Ischemic Depolarization Is the Major Cause of Rapid Reversible Damage to Dendrites and Spines
J. Neurosci., February 13, 2008; 28(7): 1756 - 1772.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. H.-C. Lin, N. Lou, N. Kang, T. Takano, F. Hu, X. Han, Q. Xu, D. Lovatt, A. Torres, K. Willecke, et al.
A Central Role of Connexin 43 in Hypoxic Preconditioning
J. Neurosci., January 16, 2008; 28(3): 681 - 695.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. P. Obrenovitch
Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia
Physiol Rev, January 1, 2008; 88(1): 211 - 247.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. P. Doyle, K. L. Suchland, T. M.P. Ciesielski, N. S. Lessov, D. K. Grandy, T. S. Scanlan, and M. P. Stenzel-Poore
Novel Thyroxine Derivatives, Thyronamine and 3-iodothyronamine, Induce Transient Hypothermia and Marked Neuroprotection Against Stroke Injury
Stroke, September 1, 2007; 38(9): 2569 - 2576.
[Abstract] [Full Text] [PDF]